Home › Research › Brain scans and imaging
In vivo retention of 18F-AV-1451 in corticobasal syndrome
Smith R, Schöll M, Widner H, van Westen D, Svenningsson P, Hägerström D, Ohlsson T, Jögi J et al.. Neurology, 2017-07-28
Topic: Brain proteins, microglia and lab models
Plain-language summary
Objective To study the usefulness of 18 F-AV-1451 PET in patients with corticobasal syndrome (CBS). Methods We recruited 8 patients with CBS, 17 controls, 31 patients with Alzheimer disease (AD), and 11 patients with progressive supranuclear palsy (PSP) from the Swedish BioFINDER study. All patients underwent clinical assessment, 18 F-AV-1451 PET, MRI, and quantification of β-amyloid pathology. A subset of participants also underwent 18 F-FDG-PET. Results In the 8 patients with CBS, 6 had imaging findings compatible with the corticobasal degeneration pathology and 2 with typical AD pathology. In the 6 patients with CBS without typical AD pathology, there were substantial retentions of 18 F-AV-1451 in the motor cortex, corticospinal tract, and basal ganglia contralateral to the most affected body side. These patients could be clearly distinguished from patients with AD dementia or PSP using 18 F-AV-1451. However, cortical atrophy was more widespread than the cortical retention of 18 F-AV1451 in these CBS cases, and cortical AV-1451 uptake did not correlate with cortical thickness or glucose hypometabolism. These results are in sharp contrast to AD dementia, where 18 F-AV-1451 retention was more widespread than cortical atrophy, and correlated well with cortical thickness and hypometabolism. Conclusions Patients with CBS without typical AD pathology exhibited AV-1451 retention in the motor cortex, corticospinal tract, and basal ganglia contralateral to the affected body side, clearly different from controls and patients with AD dementia or PSP. However, cortical atrophy measured with MRI and decreased 18 F-fluorodeoxyglucose uptake were more widespread than 18 F-AV-1451 uptake and probably represent earlier, yet less specific, markers of CBS. Classification of evidence This study provides Class III evidence that 18 F-AV-1451 PET distinguishes between CBS and AD or PSP.
What this study adds
Evidence grade: Low
In 8 patients with corticobasal syndrome, the tau PET tracer 18F-AV-1451 showed retention in the motor cortex, corticospinal tract and basal ganglia on the side opposite the most affected body side, unlike the pattern seen in Alzheimer's disease dementia. This small imaging study is about distinguishing conditions, not about treating, curing or preventing Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Smith, R., Schöll, M., Widner, H., van Westen, D., Svenningsson, P., Hägerström, D., et al. (2017). In vivo retention of 18F-AV-1451 in corticobasal syndrome. Neurology. https://doi.org/10.1212/wnl.0000000000004264
Vancouver
Smith R, Schöll M, Widner H, van Westen D, Svenningsson P, Hägerström D, et al. In vivo retention of 18F-AV-1451 in corticobasal syndrome. Neurology. 2017. doi:10.1212/wnl.0000000000004264. PMID: 28754841.
BibTeX
@article{smith2017-28754841,
author = {Smith, R. and Schöll, M. and Widner, H. and van Westen, D. and Svenningsson, P. and Hägerström, D. and Ohlsson, T. and Jögi, J. and others},
title = {{In vivo retention of 18F-AV-1451 in corticobasal syndrome}},
journal = {Neurology},
year = {2017},
doi = {10.1212/wnl.0000000000004264},
pmid = {28754841},
url = {https://doi.org/10.1212/wnl.0000000000004264}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results In the 8 patients with CBS, 6 had imaging findings compatible with the corticobasal degeneration pathology and 2 with typical AD pathology.
- These results are in sharp contrast to AD dementia, where 18 F-AV-1451 retention was more widespread than cortical atrophy, and correlated well with cortical thickness and hypometabolism.
Why it matters
In 8 patients with corticobasal syndrome, the tau PET tracer 18F-AV-1451 showed retention in the motor cortex, corticospinal tract and basal ganglia on the side opposite the most affected body side, unlike the pattern seen in Alzheimer's disease dementia. This small imaging study is about distinguishing conditions, not about treating, curing or preventing Alzheimer's disease.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Evidence strengthLow
How this study scored 51/100
Published in a leading specialty journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2017 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 117 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 10.6 citations a year over 11 year(s) since 2017 |
| Impact for its field and year | 4 / 6 | Cited 11.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 5 other studies in this library |
| Still being cited | 1 / 4 | Cited 14 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Oskar Hansson: h-index 148 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Lund University: institution h-index 1,119 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 28754841) |
| Free to read | 2 / 2 | Free to read |
| Total | 51 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
5 studies in the alzhub library list this one in their references.
Related studies in Brain scans and imaging from nearby years
Also tagged “small”
900 studies in the library carry the topic tag “small”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 900 tagged studies.